Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Suprane
Active Ingredient: Desflurane 100%
Dosage Form: Volatile liquid for inhalation
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: Baxter Healthcare Corporation of Puerto Rico, Guayama, Puerto Rico
Product: Typh-Vax (oral) vaccine
Active Ingredient: Salmonella typhi strain TY21A Berna 2,000 million organisms
Dosage Form: Modified release capsule
New Zealand Sponsor: CSL New Zealand Limited
Manufacturer: Berna Biotech AG, Berne, Switzerland
Dated this 11th day of July 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).